You are:

Bookmark this page

Asthma & COPD

29 - 30 March 2017

Location: Holiday Inn Kensington Forum, London UK
Contact: For details or to register, visit the website at or contact the team at +44(0) 207827 6000, email

SMi is delighted to announce the return of the 13th annual Asthma & COPD conference taking place in London, UK on the 29th-30th March 2017. Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases.

With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore ongoing issues, cutting edge developments and novel approaches to treatment surrounding key areas such as biomarkers and targeted treatment, device development and drug delivery. Furthermore the event will deepen understanding of the problems relating to these respiratory diseases, and discuss the hot topic of electronic health monitoring.

Featured Speakers:

Quan Yang, Pharmaceutical Assessor, MHRA

Stephen Beckman, Head of Global Respiratory and Allergy, Mylan

Outi Vaarala, Vice President, Head of Translational Biology, AstraZeneca

Ewan Walters, Medical Director, Teva UK

David Leather, Global Medical Affairs Leader, GlaxoSmithKline

Stefan Leiner, Chemical-Pharmaceutical Expert, Boehringer Ingelheim

Neelima Khairatkar Joshi, Senior Vice President & Head of Drug Discovery, Glenmark Pharmaceuticals

Christopher Stevenson, Venture Leader COPD Interception, Janssen

Marianna Alacqua, Senior Global Medical Affairs Leader of Respiratory Biologics, AstraZeneca

Frank Thielmann, Operational Lead Inhalation New Solids, Novartis 

and many more...


Exclusive highlights in 2017:

 • Updates from the MHRA on the regulatory challenge to developing inhalation devices

Overcome hurdles to the success of new devices with Boehringer Ingelheim

Janssen’s innovative approaches to COPD interception

Track the emerging trends in targeted treatment with biomarkers and biologics with MedImmune

Real time data collection’ – an exclusive case study presentation on GSK’s pioneering ‘Salford Lung study’

Early birds available.
For details or to register, visit the website at or contact the team at +44(0) 207827 6000, email 


Return to events listings

RSS Icon

TIP: You can have new content delivered directly to your email by subscribing to the RSS Feed at the bottom of the page.

  • Association for Respiratory Technology & Physiology
    • Tel: 0845 226 3062
    • Fax: 0121 355 2420
    • Limited Company No. 5987719
    • Registered Charity No. 1117470
    • Connect with us